alpha by @dming

Alnylam Pharmaceuticals

ALNY

HealthcareBiotechnology$30.3B market cap

Meridian score86Top 20% of 700as of Oct 27Strong

QualityQuality: 96th percentile

MomentumMomentum: 14th percentile

GrowthGrowth: 97th percentile

ValuationValuation: 23rd percentile

ExpectationsExpectations: 3rd percentile

ResearchNot researched

Stage and trend

Stage 4 · DecliningAbove 21d: noAbove 50d: noAbove 200d: no50d over 200d: no

Weeks in stage35 · week open

30-week lineFalling

From 30-week line-14.9%

Price · Oct 27$226.79

From 52w high-53.3%

Relative volume1.2x

1M-11.2%

3M-20.9%

6M-24.9%